PEMBROLIZUMAB

pembrolizumab 100 mg/4 mL injection, 4 mL vial

PEMBROLIZUMAB (10493G)

pembrolizumab 100 mg/4 mL injection, 4 mL vial
10493G
Body System:
Manner of administration:Injection
Public
Chemotherapy Items for Public Hospital use
Authority Required (STREAMLINED)

Restriction (Streamlined authority code: 16950)

Indication: Unresectable Stage III or Stage IV malignant melanoma
Treatment phase: Initial treatment - 3 weekly treatment regimen
Quantities & Cost
Max amount # of repeats DPMA Max safety net General Patient Charge
Max amount: 200 mg # of repeats: 5 DPMA: $7,356.35 Max safety net: $25.00 General Patient Charge: $25.00
Available brands
Keytruda
(pembrolizumab 100 mg/4 mL injection, 4 mL vial)